Par Drugs and Chemicals Limited (NSE:PAR)
India · Delayed Price · Currency is INR 118.00
+4.83 (4.27%)
Nov 11, 2026, 1:51 PM IST
Par Drugs and Chemicals Market Cap
Par Drugs and Chemicals has a market cap or net worth of 1.45 billion as of November 10, 2026. It is the 38,829th most valuable company in the world and the 3,058th biggest in India. Its market cap has increased by 20.32% in one year.
Market Cap
1.45B
Enterprise Value
1.09B
Revenue
1.08B
Global Rank
Country Rank
#3,058 India
PE Ratio
11.17
ChartMarket Cap Chart
Since May 16, 2019, Par Drugs and Chemicals's market cap has increased from 310.38M to 1.45B, an increase of 367.79%. That is a compound annual growth rate of 22.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 1.45B | 16.53% |
| Dec 31, 2025 | 1.25B | -49.09% |
| Dec 31, 2024 | 2.45B | -7.79% |
| Dec 29, 2023 | 2.65B | 42.80% |
| Dec 30, 2022 | 1.86B | -24.94% |
| Dec 31, 2021 | 2.48B | 451.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bafna Pharmaceuticals | 11.18B |
| Sigachi Industries | 10.39B |
| Amanta Healthcare | 7.85B |
| Valiant Laboratories | 6.06B |
| Nectar Lifesciences | 2.00B |
| Brooks Laboratories | 1.94B |
| Balaxi Pharmaceuticals | 1.26B |
| Alpa Laboratories | 1.19B |